 | • レポートコード：MRC2-11QY01538 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は特発性低身長治療薬のグローバル市場について調査・分析したレポートです。種類別（BBT-031、MMP-0201、ソマトロピン、ソマトロピンS、その他）市場規模、用途別（研究センター、病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別特発性低身長治療薬の競争状況、市場シェア ・世界の特発性低身長治療薬市場：種類別市場規模 2015年-2020年（BBT-031、MMP-0201、ソマトロピン、ソマトロピンS、その他） ・世界の特発性低身長治療薬市場：種類別市場規模予測 2021年-2026年（BBT-031、MMP-0201、ソマトロピン、ソマトロピンS、その他） ・世界の特発性低身長治療薬市場：用途別市場規模 2015年-2020年（研究センター、病院、クリニック） ・世界の特発性低身長治療薬市場：用途別市場規模予測 2021年-2026年（研究センター、病院、クリニック） ・北米の特発性低身長治療薬市場分析：米国、カナダ ・ヨーロッパの特発性低身長治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの特発性低身長治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の特発性低身長治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの特発性低身長治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：JCR Pharmaceuticals Co., Ltd.、LG Life Sciences, Ltd.、Myungmoon pharmaceutical Co.,Ltd.、Braasch Biotech LLC、Bolder Biotechnology, Inc.、Dong-A Socio Holdings Co Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Idiopathic Short Stature Drug Market
The global Idiopathic Short Stature Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Idiopathic Short Stature Drug Scope and Market Size
Idiopathic Short Stature Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Idiopathic Short Stature Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Idiopathic Short Stature Drug market is segmented into
BBT-031
MMP-0201
Somatropin
Somatropin S
Others
Segment by Application, the Idiopathic Short Stature Drug market is segmented into
Research Center
Hospital
Clinic
Regional and Country-level Analysis
The Idiopathic Short Stature Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Idiopathic Short Stature Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Idiopathic Short Stature Drug Market Share Analysis
Idiopathic Short Stature Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Idiopathic Short Stature Drug business, the date to enter into the Idiopathic Short Stature Drug market, Idiopathic Short Stature Drug product introduction, recent developments, etc.
The major vendors covered:
JCR Pharmaceuticals Co., Ltd.
LG Life Sciences, Ltd.
Myungmoon pharmaceutical Co.,Ltd.
Braasch Biotech LLC
Bolder Biotechnology, Inc.
Dong-A Socio Holdings Co Ltd
…
1 Study Coverage
1.1 Idiopathic Short Stature Drug Product Introduction
1.2 Market Segments
1.3 Key Idiopathic Short Stature Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Idiopathic Short Stature Drug Market Size Growth Rate by Type
1.4.2 BBT-031
1.4.3 MMP-0201
1.4.4 Somatropin
1.4.5 Somatropin S
1.4.6 Others
1.5 Market by Application
1.5.1 Global Idiopathic Short Stature Drug Market Size Growth Rate by Application
1.5.2 Research Center
1.5.3 Hospital
1.5.4 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Idiopathic Short Stature Drug Market Size, Estimates and Forecasts
2.1.1 Global Idiopathic Short Stature Drug Revenue 2015-2026
2.1.2 Global Idiopathic Short Stature Drug Sales 2015-2026
2.2 Global Idiopathic Short Stature Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Idiopathic Short Stature Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Idiopathic Short Stature Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Idiopathic Short Stature Drug Competitor Landscape by Players
3.1 Idiopathic Short Stature Drug Sales by Manufacturers
3.1.1 Idiopathic Short Stature Drug Sales by Manufacturers (2015-2020)
3.1.2 Idiopathic Short Stature Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Idiopathic Short Stature Drug Revenue by Manufacturers
3.2.1 Idiopathic Short Stature Drug Revenue by Manufacturers (2015-2020)
3.2.2 Idiopathic Short Stature Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Idiopathic Short Stature Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Idiopathic Short Stature Drug Revenue in 2019
3.2.5 Global Idiopathic Short Stature Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Idiopathic Short Stature Drug Price by Manufacturers
3.4 Idiopathic Short Stature Drug Manufacturing Base Distribution, Product Types
3.4.1 Idiopathic Short Stature Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Idiopathic Short Stature Drug Product Type
3.4.3 Date of International Manufacturers Enter into Idiopathic Short Stature Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Idiopathic Short Stature Drug Market Size by Type (2015-2020)
4.1.1 Global Idiopathic Short Stature Drug Sales by Type (2015-2020)
4.1.2 Global Idiopathic Short Stature Drug Revenue by Type (2015-2020)
4.1.3 Idiopathic Short Stature Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Idiopathic Short Stature Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Idiopathic Short Stature Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Idiopathic Short Stature Drug Revenue Forecast by Type (2021-2026)
4.2.3 Idiopathic Short Stature Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Idiopathic Short Stature Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Idiopathic Short Stature Drug Market Size by Application (2015-2020)
5.1.1 Global Idiopathic Short Stature Drug Sales by Application (2015-2020)
5.1.2 Global Idiopathic Short Stature Drug Revenue by Application (2015-2020)
5.1.3 Idiopathic Short Stature Drug Price by Application (2015-2020)
5.2 Idiopathic Short Stature Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Idiopathic Short Stature Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Idiopathic Short Stature Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Idiopathic Short Stature Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Idiopathic Short Stature Drug by Country
6.1.1 North America Idiopathic Short Stature Drug Sales by Country
6.1.2 North America Idiopathic Short Stature Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Idiopathic Short Stature Drug Market Facts & Figures by Type
6.3 North America Idiopathic Short Stature Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Idiopathic Short Stature Drug by Country
7.1.1 Europe Idiopathic Short Stature Drug Sales by Country
7.1.2 Europe Idiopathic Short Stature Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Idiopathic Short Stature Drug Market Facts & Figures by Type
7.3 Europe Idiopathic Short Stature Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Idiopathic Short Stature Drug by Region
8.1.1 Asia Pacific Idiopathic Short Stature Drug Sales by Region
8.1.2 Asia Pacific Idiopathic Short Stature Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Idiopathic Short Stature Drug Market Facts & Figures by Type
8.3 Asia Pacific Idiopathic Short Stature Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Idiopathic Short Stature Drug by Country
9.1.1 Latin America Idiopathic Short Stature Drug Sales by Country
9.1.2 Latin America Idiopathic Short Stature Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Idiopathic Short Stature Drug Market Facts & Figures by Type
9.3 Central & South America Idiopathic Short Stature Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Idiopathic Short Stature Drug by Country
10.1.1 Middle East and Africa Idiopathic Short Stature Drug Sales by Country
10.1.2 Middle East and Africa Idiopathic Short Stature Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Idiopathic Short Stature Drug Market Facts & Figures by Type
10.3 Middle East and Africa Idiopathic Short Stature Drug Market Facts & Figures by Application
11 Company Profiles
11.1 JCR Pharmaceuticals Co., Ltd.
11.1.1 JCR Pharmaceuticals Co., Ltd. Corporation Information
11.1.2 JCR Pharmaceuticals Co., Ltd. Description and Business Overview
11.1.3 JCR Pharmaceuticals Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 JCR Pharmaceuticals Co., Ltd. Idiopathic Short Stature Drug Products Offered
11.1.5 JCR Pharmaceuticals Co., Ltd. Related Developments
11.2 LG Life Sciences, Ltd.
11.2.1 LG Life Sciences, Ltd. Corporation Information
11.2.2 LG Life Sciences, Ltd. Description and Business Overview
11.2.3 LG Life Sciences, Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 LG Life Sciences, Ltd. Idiopathic Short Stature Drug Products Offered
11.2.5 LG Life Sciences, Ltd. Related Developments
11.3 Myungmoon pharmaceutical Co.,Ltd.
11.3.1 Myungmoon pharmaceutical Co.,Ltd. Corporation Information
11.3.2 Myungmoon pharmaceutical Co.,Ltd. Description and Business Overview
11.3.3 Myungmoon pharmaceutical Co.,Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Myungmoon pharmaceutical Co.,Ltd. Idiopathic Short Stature Drug Products Offered
11.3.5 Myungmoon pharmaceutical Co.,Ltd. Related Developments
11.4 Braasch Biotech LLC
11.4.1 Braasch Biotech LLC Corporation Information
11.4.2 Braasch Biotech LLC Description and Business Overview
11.4.3 Braasch Biotech LLC Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Braasch Biotech LLC Idiopathic Short Stature Drug Products Offered
11.4.5 Braasch Biotech LLC Related Developments
11.5 Bolder Biotechnology, Inc.
11.5.1 Bolder Biotechnology, Inc. Corporation Information
11.5.2 Bolder Biotechnology, Inc. Description and Business Overview
11.5.3 Bolder Biotechnology, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bolder Biotechnology, Inc. Idiopathic Short Stature Drug Products Offered
11.5.5 Bolder Biotechnology, Inc. Related Developments
11.6 Dong-A Socio Holdings Co Ltd
11.6.1 Dong-A Socio Holdings Co Ltd Corporation Information
11.6.2 Dong-A Socio Holdings Co Ltd Description and Business Overview
11.6.3 Dong-A Socio Holdings Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Dong-A Socio Holdings Co Ltd Idiopathic Short Stature Drug Products Offered
11.6.5 Dong-A Socio Holdings Co Ltd Related Developments
11.1 JCR Pharmaceuticals Co., Ltd.
11.1.1 JCR Pharmaceuticals Co., Ltd. Corporation Information
11.1.2 JCR Pharmaceuticals Co., Ltd. Description and Business Overview
11.1.3 JCR Pharmaceuticals Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 JCR Pharmaceuticals Co., Ltd. Idiopathic Short Stature Drug Products Offered
11.1.5 JCR Pharmaceuticals Co., Ltd. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Idiopathic Short Stature Drug Market Estimates and Projections by Region
12.1.1 Global Idiopathic Short Stature Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Idiopathic Short Stature Drug Revenue Forecast by Regions 2021-2026
12.2 North America Idiopathic Short Stature Drug Market Size Forecast (2021-2026)
12.2.1 North America: Idiopathic Short Stature Drug Sales Forecast (2021-2026)
12.2.2 North America: Idiopathic Short Stature Drug Revenue Forecast (2021-2026)
12.2.3 North America: Idiopathic Short Stature Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Idiopathic Short Stature Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Idiopathic Short Stature Drug Sales Forecast (2021-2026)
12.3.2 Europe: Idiopathic Short Stature Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Idiopathic Short Stature Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Idiopathic Short Stature Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Idiopathic Short Stature Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Idiopathic Short Stature Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Idiopathic Short Stature Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Idiopathic Short Stature Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Idiopathic Short Stature Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Idiopathic Short Stature Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Idiopathic Short Stature Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Idiopathic Short Stature Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Idiopathic Short Stature Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Idiopathic Short Stature Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Idiopathic Short Stature Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Idiopathic Short Stature Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Idiopathic Short Stature Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Idiopathic Short Stature Drug Market Segments
Table 2. Ranking of Global Top Idiopathic Short Stature Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Idiopathic Short Stature Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of BBT-031
Table 5. Major Manufacturers of MMP-0201
Table 6. Major Manufacturers of Somatropin
Table 7. Major Manufacturers of Somatropin S
Table 8. Major Manufacturers of Others
Table 9. Global Idiopathic Short Stature Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Idiopathic Short Stature Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Idiopathic Short Stature Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Idiopathic Short Stature Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Idiopathic Short Stature Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Idiopathic Short Stature Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Idiopathic Short Stature Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Idiopathic Short Stature Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Idiopathic Short Stature Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Idiopathic Short Stature Drug as of 2019)
Table 18. Idiopathic Short Stature Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Idiopathic Short Stature Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Idiopathic Short Stature Drug Price (2015-2020) (USD/Pcs)
Table 21. Idiopathic Short Stature Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Idiopathic Short Stature Drug Product Type
Table 23. Date of International Manufacturers Enter into Idiopathic Short Stature Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Idiopathic Short Stature Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Idiopathic Short Stature Drug Sales Share by Type (2015-2020)
Table 27. Global Idiopathic Short Stature Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Idiopathic Short Stature Drug Revenue Share by Type (2015-2020)
Table 29. Idiopathic Short Stature Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Idiopathic Short Stature Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Idiopathic Short Stature Drug Sales Share by Application (2015-2020)
Table 32. North America Idiopathic Short Stature Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Idiopathic Short Stature Drug Sales Market Share by Country (2015-2020)
Table 34. North America Idiopathic Short Stature Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Idiopathic Short Stature Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Idiopathic Short Stature Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Idiopathic Short Stature Drug Sales Market Share by Type (2015-2020)
Table 38. North America Idiopathic Short Stature Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Idiopathic Short Stature Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Idiopathic Short Stature Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Idiopathic Short Stature Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Idiopathic Short Stature Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Idiopathic Short Stature Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Idiopathic Short Stature Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Idiopathic Short Stature Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Idiopathic Short Stature Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Idiopathic Short Stature Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Idiopathic Short Stature Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Idiopathic Short Stature Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Idiopathic Short Stature Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Idiopathic Short Stature Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Idiopathic Short Stature Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Idiopathic Short Stature Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Idiopathic Short Stature Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Idiopathic Short Stature Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Idiopathic Short Stature Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Idiopathic Short Stature Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Idiopathic Short Stature Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Idiopathic Short Stature Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Idiopathic Short Stature Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Idiopathic Short Stature Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Idiopathic Short Stature Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Idiopathic Short Stature Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Idiopathic Short Stature Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Idiopathic Short Stature Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Idiopathic Short Stature Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Idiopathic Short Stature Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Idiopathic Short Stature Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Idiopathic Short Stature Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Idiopathic Short Stature Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Idiopathic Short Stature Drug Sales Market Share by Application (2015-2020)
Table 72. JCR Pharmaceuticals Co., Ltd. Corporation Information
Table 73. JCR Pharmaceuticals Co., Ltd. Description and Major Businesses
Table 74. JCR Pharmaceuticals Co., Ltd. Idiopathic Short Stature Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. JCR Pharmaceuticals Co., Ltd. Product
Table 76. JCR Pharmaceuticals Co., Ltd. Recent Development
Table 77. LG Life Sciences, Ltd. Corporation Information
Table 78. LG Life Sciences, Ltd. Description and Major Businesses
Table 79. LG Life Sciences, Ltd. Idiopathic Short Stature Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. LG Life Sciences, Ltd. Product
Table 81. LG Life Sciences, Ltd. Recent Development
Table 82. Myungmoon pharmaceutical Co.,Ltd. Corporation Information
Table 83. Myungmoon pharmaceutical Co.,Ltd. Description and Major Businesses
Table 84. Myungmoon pharmaceutical Co.,Ltd. Idiopathic Short Stature Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Myungmoon pharmaceutical Co.,Ltd. Product
Table 86. Myungmoon pharmaceutical Co.,Ltd. Recent Development
Table 87. Braasch Biotech LLC Corporation Information
Table 88. Braasch Biotech LLC Description and Major Businesses
Table 89. Braasch Biotech LLC Idiopathic Short Stature Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Braasch Biotech LLC Product
Table 91. Braasch Biotech LLC Recent Development
Table 92. Bolder Biotechnology, Inc. Corporation Information
Table 93. Bolder Biotechnology, Inc. Description and Major Businesses
Table 94. Bolder Biotechnology, Inc. Idiopathic Short Stature Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Bolder Biotechnology, Inc. Product
Table 96. Bolder Biotechnology, Inc. Recent Development
Table 97. Dong-A Socio Holdings Co Ltd Corporation Information
Table 98. Dong-A Socio Holdings Co Ltd Description and Major Businesses
Table 99. Dong-A Socio Holdings Co Ltd Idiopathic Short Stature Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Dong-A Socio Holdings Co Ltd Product
Table 101. Dong-A Socio Holdings Co Ltd Recent Development
Table 102. Global Idiopathic Short Stature Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 103. Global Idiopathic Short Stature Drug Sales Market Share Forecast by Regions (2021-2026)
Table 104. Global Idiopathic Short Stature Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 105. Global Idiopathic Short Stature Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 106. North America: Idiopathic Short Stature Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 107. North America: Idiopathic Short Stature Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Europe: Idiopathic Short Stature Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Europe: Idiopathic Short Stature Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Asia Pacific: Idiopathic Short Stature Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 111. Asia Pacific: Idiopathic Short Stature Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 112. Latin America: Idiopathic Short Stature Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 113. Latin America: Idiopathic Short Stature Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Middle East and Africa: Idiopathic Short Stature Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 115. Middle East and Africa: Idiopathic Short Stature Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 117. Key Challenges
Table 118. Market Risks
Table 119. Main Points Interviewed from Key Idiopathic Short Stature Drug Players
Table 120. Idiopathic Short Stature Drug Customers List
Table 121. Idiopathic Short Stature Drug Distributors List
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Idiopathic Short Stature Drug Product Picture
Figure 2. Global Idiopathic Short Stature Drug Sales Market Share by Type in 2020 & 2026
Figure 3. BBT-031 Product Picture
Figure 4. MMP-0201 Product Picture
Figure 5. Somatropin Product Picture
Figure 6. Somatropin S Product Picture
Figure 7. Others Product Picture
Figure 8. Global Idiopathic Short Stature Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Research Center
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Idiopathic Short Stature Drug Report Years Considered
Figure 13. Global Idiopathic Short Stature Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Idiopathic Short Stature Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Idiopathic Short Stature Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Idiopathic Short Stature Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Idiopathic Short Stature Drug Sales Market Share by Region in 2019
Figure 18. Global Idiopathic Short Stature Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Idiopathic Short Stature Drug Revenue Market Share by Region in 2019
Figure 20. Global Idiopathic Short Stature Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Idiopathic Short Stature Drug Revenue in 2019
Figure 22. Idiopathic Short Stature Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Idiopathic Short Stature Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Idiopathic Short Stature Drug Sales Market Share by Type in 2019
Figure 25. Global Idiopathic Short Stature Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Idiopathic Short Stature Drug Revenue Market Share by Type in 2019
Figure 27. Global Idiopathic Short Stature Drug Market Share by Price Range (2015-2020)
Figure 28. Global Idiopathic Short Stature Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Idiopathic Short Stature Drug Sales Market Share by Application in 2019
Figure 30. Global Idiopathic Short Stature Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Idiopathic Short Stature Drug Revenue Market Share by Application in 2019
Figure 32. North America Idiopathic Short Stature Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Idiopathic Short Stature Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Idiopathic Short Stature Drug Sales Market Share by Country in 2019
Figure 35. North America Idiopathic Short Stature Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Idiopathic Short Stature Drug Market Share by Type in 2019
Figure 41. North America Idiopathic Short Stature Drug Market Share by Application in 2019
Figure 42. Europe Idiopathic Short Stature Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Idiopathic Short Stature Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Idiopathic Short Stature Drug Sales Market Share by Country in 2019
Figure 45. Europe Idiopathic Short Stature Drug Revenue Market Share by Country in 2019
Figure 46. Germany Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Idiopathic Short Stature Drug Market Share by Type in 2019
Figure 57. Europe Idiopathic Short Stature Drug Market Share by Application in 2019
Figure 58. Asia Pacific Idiopathic Short Stature Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Idiopathic Short Stature Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Idiopathic Short Stature Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Idiopathic Short Stature Drug Revenue Market Share by Region in 2019
Figure 62. China Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Idiopathic Short Stature Drug Market Share by Type in 2019
Figure 85. Asia Pacific Idiopathic Short Stature Drug Market Share by Application in 2019
Figure 86. Latin America Idiopathic Short Stature Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Idiopathic Short Stature Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Idiopathic Short Stature Drug Sales Market Share by Country in 2019
Figure 89. Latin America Idiopathic Short Stature Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Idiopathic Short Stature Drug Market Share by Type in 2019
Figure 97. Latin America Idiopathic Short Stature Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Idiopathic Short Stature Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Idiopathic Short Stature Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Idiopathic Short Stature Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Idiopathic Short Stature Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Idiopathic Short Stature Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Idiopathic Short Stature Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Idiopathic Short Stature Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Idiopathic Short Stature Drug Market Share by Application in 2019
Figure 110. North America Idiopathic Short Stature Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Idiopathic Short Stature Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Idiopathic Short Stature Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Idiopathic Short Stature Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Idiopathic Short Stature Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Idiopathic Short Stature Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Idiopathic Short Stature Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Idiopathic Short Stature Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Idiopathic Short Stature Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Idiopathic Short Stature Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
多関節若年性特発性関節炎治療薬の世界市場（～2026年） Market Analysis and Insights: Global Polyarticular Juvenile Idiopathic Arthritis Drug Market The global Polyarticular Juvenile Idiopathic Arthritis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Polyarticular Juv…- 慢性特発性骨髄線維症の世界市場（～2026年） Idiopathic myelofibrosis is a chronic myelo-proliferative disorder and characterized by abnormal mutation of stem cells. This abnormal mutation of stem cells and excessive production of platelets result in development of fibrous tissues within the bone-marrow. This factor would ultimately negatively…
- 特発性肺線維症（IPF）の世界市場（～2026年） Idiopathic pulmonary fibrosis is a condition in which the tissues in the lungs become thick and stiff over time. As a result of thickening of lung tissues, brain and other organs are unable receive optimum oxygen. An increase in the incidence and prevalence of fibrotic diseases is the primary driver…
- 特発性頭蓋内圧亢進症治療薬の世界市場（～2026年） A drug used to treat idiopathic intracranial hypertension. Market Analysis and Insights: Global Idiopathic Intracranial Hypertension Therapeutics Market The global Idiopathic Intracranial Hypertension Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020,…
- 全身性特発性若年性関節炎治療の世界市場（～2026年） Market Analysis and Insights: Global Systemic Idiopathic Juvenile Arthritis Treatment Market The global Systemic Idiopathic Juvenile Arthritis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Systemic Idiopath…